9/22/2020  10:00:00 PM Chg. - Volume Bid7/30/2020 Ask10/10/2019 Market Capitalization Dividend Y. P/E Ratio
45.200CHF - -
Turnover: -
45.000Bid Size: 10 275.300Ask Size: 200 13.85 bill.CHF - -

Business description

Novozymes is the world leader in biological solutions. As the world’s largest provider of enzyme and microbial technologies, the company´s bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits.
 

Management board & Supervisory board

CEO
Ester Baiget
Management board
Lars Green, Andrew Fordyce, Thomas Videbæk, Tina Sejersgård Fanø
Supervisory board
Jørgen Buhl Rasmussen, Andreas Hentze Knudsen, Cees de Jong, Heine Dalsgaard, Kasim Kutay, Kim Stratton, Lars Bo Køppler, Lena Bech Holskov, Mathias Uhlén, Sharon James
 

Company data

Name: Novozymes A.S
Address: Krogshoejvej 36,DK-2880 Bagsvaerd
Phone: +45-44-460000
Fax: -
E-mail: -
Internet: www.novozymes.com/
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 12/31
Free Float: 50.00%
IPO date: 11/20/2000

Investor relations

Name: Tobias Cornelius Björklund
IR phone: +45-3077-8682
IR Fax: -
IR e-mail: NovozymesIR@novozymes.com

Company calendar

CW 43 | 10/21/2020 Interim Report 3rd Quarter/9 Months
CW 6 | 2/2/2021 4th Quarter/Annual Report
CW 11 | 3/11/2021 General Shareholder Meeting
 

Main Shareholders

Novo A/S
 
50.00%
Freefloat
 
50.00%